N.Y. Lawmakers Oppose Ban on Race-Day Salix
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
The measure would ban the use of furosemide on race-day in graded and listed stakes over a three-year period.
The AGSC supports a ban on all race-day medication in graded stakes race for 2-year-old Thoroughbreds.
Roughly 15 individuals commented on the KHRC Salix phase-out proposal, with only one in support of the measure
The new guidelines will be “based on the latest science, testing technology, and veterinarian expertise.”
The Salix debate will continue in early June when the KHRC holds a town hall meeting on the topic.
The Kentucky Horse Racing Commission reported successful Kentucky Oaks and Kentucky Derby Presented by Y
The KHRC will discuss a possible three-year phase-out of race-day furosemide in graded and listed stakes.
Furosemide, also known as Salix or Lasix, is the only therapeutic medication widely used on race day.
The witnesses all told Congress they don’t believe race-day medication has a place in Thoroughbred racing.
The last congressional hearing on horse racing was held in June 2008 and dealt with similar issues.
Revised regulations adopted by the West Virginia Racing Commission (WVRC) would allow the agency to take action against permit holders found to have knowingly sold a horse for slaughter. The regulations also allow for action in cases of horse abuse.
Broad adoption of the new medication policies hinges on action by regulators in all racing jurisdictions.
In the wake of a March 25 New York Times report, Udall renewed his call for safety and integrity regulation.
The survey will include all breeds and disciplines of horses, as well as ponies, mules, and donkeys.
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Stay on top of the most recent Horse Health news with